Articles published by Neumora Therapeutics, Inc.
![](https://ml.globenewswire.com/media/48256578-6cd3-4332-bf9b-2f52cfa248b7/small/neumora-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/48256578-6cd3-4332-bf9b-2f52cfa248b7/small/neumora-logo-jpg.jpg)
Neumora Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
August 06, 2024
Via GlobeNewswire
Tickers
NMRA
![](https://ml.globenewswire.com/media/48256578-6cd3-4332-bf9b-2f52cfa248b7/small/neumora-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/48256578-6cd3-4332-bf9b-2f52cfa248b7/small/neumora-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/48256578-6cd3-4332-bf9b-2f52cfa248b7/small/neumora-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/48256578-6cd3-4332-bf9b-2f52cfa248b7/small/neumora-logo-jpg.jpg)
Via GlobeNewswire
Tickers
NMRA
![](https://ml.globenewswire.com/media/48256578-6cd3-4332-bf9b-2f52cfa248b7/small/neumora-logo-jpg.jpg)
Via GlobeNewswire
Tickers
NMRA
![](https://ml.globenewswire.com/media/48256578-6cd3-4332-bf9b-2f52cfa248b7/small/neumora-logo-jpg.jpg)
Via GlobeNewswire
Tickers
NMRA
![](https://ml.globenewswire.com/media/48256578-6cd3-4332-bf9b-2f52cfa248b7/small/neumora-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/48256578-6cd3-4332-bf9b-2f52cfa248b7/small/neumora-logo-jpg.jpg)
Via GlobeNewswire
Tickers
NMRA
![](https://ml.globenewswire.com/media/48256578-6cd3-4332-bf9b-2f52cfa248b7/small/neumora-logo-jpg.jpg)
Via GlobeNewswire
Tickers
NMRA
![](https://ml.globenewswire.com/media/48256578-6cd3-4332-bf9b-2f52cfa248b7/small/neumora-logo-jpg.jpg)
Neumora Therapeutics Appoints Jason Duncan as Chief Legal Officer
December 12, 2023
Via GlobeNewswire
Tickers
NMRA
![](https://ml.globenewswire.com/media/48256578-6cd3-4332-bf9b-2f52cfa248b7/small/neumora-logo-jpg.jpg)
Neumora Therapeutics Announces NMRA-266 IND Clearance and Initiation of Phase 1 Clinical Study
November 27, 2023
Via GlobeNewswire
Tickers
NMRA
![](https://ml.globenewswire.com/media/48256578-6cd3-4332-bf9b-2f52cfa248b7/small/neumora-logo-jpg.jpg)
Neumora Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
November 01, 2023
Via GlobeNewswire
Tickers
NMRA
![](https://www.globenewswire.com/Content/Images/intrado.png)
Via GlobeNewswire
Tickers
NMRA
![](https://www.globenewswire.com/Content/Images/intrado.png)
![](https://www.globenewswire.com/Content/Images/intrado.png)
Neumora Therapeutics Announces Pricing of Initial Public Offering
September 14, 2023
Via GlobeNewswire
![](https://mms.businesswire.com/media/20230718207734/en/1842864/5/Neumora_Logos_1-6_A-01.jpg)
![](https://mms.businesswire.com/media/20230718386025/en/1842912/22/Henry_Gosebruch_Neumora_Headshot.jpg)
![](https://mms.businesswire.com/media/20221011005203/en/1596821/4/neumora.jpg)
Neumora Therapeutics Announces $112 Million Series B Financing
October 11, 2022
Via Business Wire
![](https://mms.businesswire.com/media/20220217005341/en/1363121/5/Neumora_Logos_1-6_A-01.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.